Characterization of PD-1/PD-L1 immune checkpoint expression in soft tissue sarcomas

Inhibitors of the programmed death-1/programmed death-ligand 1 (PD-1/PD-L1) immune checkpoint system are used for treating various malignancies. However, evidence on their use in soft tissue sarcomas (STS) is limited. This study aimed to retrospectively investigate the relationship between the expre...

Descripción completa

Detalles Bibliográficos
Autores principales: Hashimoto, Kazuhiko, Nishimura, Shunji, Ito, Tomohiko, Akagi, Masao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PAGEPress Publications, Pavia, Italy 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273625/
https://www.ncbi.nlm.nih.gov/pubmed/34218652
http://dx.doi.org/10.4081/ejh.2021.3203

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273625/
https://www.ncbi.nlm.nih.gov/pubmed/34218652
http://dx.doi.org/10.4081/ejh.2021.3203

Ejemplares similares